About Genefluidics
Genefluidics is a Healthcare company based in Irwindale (United States) founded in 2000. Electrochemical sensor for rapid diagnosis of urinary tract infections (UTIs). Its focus areas include Life Sciences, Genitourinary Disorders, In Vitro Diagnostic Tests and Urology. Its competitors include Bright Uro, Stream DX and Clariflow; 2 of its 3 listed competitors have raised funding.
Company details
GeneFluidics is a biomedical diagnostics company engaged in the development of rapid tests for detection of direct bloodstream infection (BSI), pathogen identification (PID) and antimicrobial susceptibility tests (AST). The company has integrated the concepts of bio-nano, microfluidic technologies and its proprietary electrochemical sensor to develop a molecular analysis platform that allows users to perform rapid immunoassays and genetic assays with sensitivity to picogramml and femtomolar concentrations, respectively. The company has developed a modular robotic system-Proteus, the multi-channel microfluidics cartridge system-Asklepios, and sensor chip arrays. The Proteus Robotic System allows quantification of multiple proteins, nucleic acids and small molecules simultaneously. The company plans to complete the clinical testing for CE marking for Proteus lab automation system, allows rapid PID and AST of urinary tract infections (UTIs) by 2016.
- Headquarters Irwindale, United States
- SectorsHealthcare
- Email••••••••
- Website genefluidics.com
- Social LinkedIn Facebook
- Latest Funding Round$4.61M (USD), Grant
May 2015
- InvestorsUCLA
& 1 more
Funding Insights of Genefluidics
- Total Rounds 9
- Last Round Grant — $4.61M
- First Round $142,000
(Mar 2004)
- Investors Count 2
All 9 funding rounds of Genefluidics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May 2015 | $4.61M | Grant | – | – | |
| Mar 2015 | $3.62M | Grant | – | – | |
| May 2012 | $2.97M | Grant | – | – | |
| Jul 2010 | $97,205 | Grant | – | – | |
| May 2010 | $434,330 | Grant | – | – | |
| Apr 2010 | $434,330 | Grant | – | – | |
| Mar 2010 | $6.66M | Grant | – | – | |
| Mar 2010 | $700,467 | Grant | – | – | |
| Mar 2004 | $142,000 | Grant | – | – |
2 investors in total: 2 institutional.
Investors in Genefluidics
Genefluidics has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include UCLA and HHS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Public health and human services are overseen by HHS. | 1953 | hhs.gov | ||
Undergraduate and postgraduate courses are offered across diversified streams. | 1919 | ucla.edu | United States |
Investor details for Genefluidics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Genefluidics
1 people are tracked at Genefluidics (1 in leadership).
| Name | Role | Group |
|---|---|---|
Vincent Gau | CEO | Leadership |
Complete people profiles for Genefluidics
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Genefluidics
3 dated milestones of Genefluidics across 15 years, from founding to its latest funding, stage changes and deals.
- Founded Genefluidics is founded.
- Funding First funding round of $142K.
- Funding Latest funding round, Grant, of $4.6M.
Competitors of Genefluidics
Genefluidics has 3 listed competitors in our database, 2 of them funded. They include Bright Uro, Stream DX and Clariflow.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| brighturo.com | 2021 | Aliso Viejo, United States | $94.99M | 23 | Diagnostic devices for lower urinary tract diseases are developed. | |
| streamdx.com | 2014 | West Valley, United States | 10 | Uro-flow meters for LUTS diagnosis and patient care are provided. | ||
| clariflow.com | 2014 | New York, United States | $100,000 | Provides DIY test kits for benign prostatic hyperplasia (BPH). |
Detailed competitors of Genefluidics
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Genitourinary Disorders
3 companies that operate in the same segment as Genefluidics (Genitourinary Disorders) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Therapeutics for drug-resistant bacterial infections are developed. | 2013 | Cambridge, Massachusetts, United States | USD 114.7 M | USD 59.62 M | 32 | |
Sacral neuromodulation devices are developed for urinary and bowel control. | 2013 | Irvine, California, United States | USD 143.47 M | |||
Provider of surgical devices for vertical hernia repair and abdominal wall reconstruction | 2012 | Malvern, Pennsylvania, United States | USD 104.6 M | USD 80.28 M | 209 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Genefluidics
Complete news archive for Genefluidics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Genefluidics
Genefluidics was founded in 2000 and raised its 1st funding round 4 years after it was founded.
Genefluidics is headquartered in Irwindale, United States. It is registered at Irwindale, California, United States.
GeneFluidics is a biomedical diagnostics company engaged in the development of rapid tests for detection of direct bloodstream infection (BSI), pathogen identification (PID) and antimicrobial susceptibility tests (AST). The company has integrated the concepts of bio-nano, microfluidic technologies and its proprietary electrochemical sensor to develop a molecular analysis platform that allows users to perform rapid immunoassays and genetic assays with sensitivity to picogramml and femtomolar concentrations, respectively. The company has developed a modular robotic system-Proteus, the multi-channel microfluidics cartridge system-Asklepios, and sensor chip arrays. The Proteus Robotic System allows quantification of multiple proteins, nucleic acids and small molecules simultaneously. The company plans to complete the clinical testing for CE marking for Proteus lab automation system, allows rapid PID and AST of urinary tract infections (UTIs) by 2016.
Genefluidics's top competitors include Bright Uro, Stream DX and Clariflow.